Acinetobacter baumannii Infections in Times of COVID-19 Pandemic

K Rangel, TPG Chagas, SG De-Simone - Pathogens, 2021 - mdpi.com
The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients.
Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive …

Acinetobacter baumannii Isolates from COVID-19 Patients in a Hospital Intensive Care Unit: Molecular Typing and Risk Factors

M Ceparano, V Baccolini, G Migliara, C Isonne… - Microorganisms, 2022 - mdpi.com
Infections caused by Acinetobacter baumannii represent a major concern for intensive care
unit (ICU) patients. However, the epidemiology of these infections among COVID-19 patients …

Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit

A Russo, F Gavaruzzi, G Ceccarelli, C Borrazzo… - Infection, 2022 - Springer
Objectives Superinfections in patients hospitalized in intensive care unit (ICU) are an
important and challenging complication, also in COVID-19. However, no definitive data are …

The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience

G Montrucchio, S Corcione, T Lupia, N Shbaklo… - Journal of clinical …, 2022 - mdpi.com
Since the beginning of the COVID-19 pandemic, the impact of superinfections in intensive
care units (ICUs) has progressively increased, especially carbapenem-resistant …

[HTML][HTML] A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically Ill patients: Clinical and microbiological …

TA Hafiz, SS Alghamdi, MA Mubaraki… - Journal of Infection and …, 2023 - Elsevier
Background Acinetobacter baumannii infection is a serious public health problem because it
is highly resistant to antimicrobial therapy and causes a high fatality rate in critically ill …

Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)–specific intensive care unit

DR Shinohara, SM dos Santos Saalfeld… - Infection Control & …, 2022 - cambridge.org
2. Wee LE, Conceicao EP, Tan JY, et al. Unintended consequences of infection prevention
and control measures during COVID-19 pandemic. Am J Infect Control 2020. doi: 10.1016/j …

Is the pendulum of antimicrobial drug resistance swinging back after COVID-19?

F Serapide, A Quirino, V Scaglione, HL Morrone… - Microorganisms, 2022 - mdpi.com
The COVID-19 pandemic may have had an effect on antimicrobial resistance. We compared
the prevalence of ESKAPE multidrug-resistant (MDR) bacterial infections in COVID-19 …

[HTML][HTML] The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: A retrospective multi-centre study

I Gajic, M Jovicevic, V Popadic, A Trudic, J Kabic… - Journal of Hospital …, 2023 - Elsevier
Introduction We evaluated the prevalence, aetiologies and antibiotic resistance patterns of
bacterial infections in hospitalized patients with laboratory-confirmed SARS-CoV-2. We also …

Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center …

M Karataş, M Yaşar-Duman, A Tünger, F Çilli… - Annals of clinical …, 2021 - Springer
Purpose In this study, we aimed to evaluate the epidemiology and antimicrobial resistance
(AMR) patterns of bacterial pathogens in COVID-19 patients and to compare the results with …

[HTML][HTML] Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?

WG Lima, JCM Brito, WS da Cruz Nizer - Medical hypotheses, 2020 - ncbi.nlm.nih.gov
In late 2019, a cluster of pneumonia cases reported from Wuhan City (Hubei Province,
China) were associated with a novel betacoronavirus, first called the 2019 novel coronavirus …